Unknown

Dataset Information

0

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.


ABSTRACT:

Background

c-Met has been recognized as an important therapeutic target in gastric cancer, but the prognostic property of the c-Met status is still unclear. We aimed to characterize the prognostic effect of c-Met by systematic review and meta-analysis.

Methods

We identified 15 studies assessing survival in gastric cancer by c-Met status. Effect measure of interest was hazard ratio (HR) for survival. Meta-regression was performed to estimate the relationship between HR and disease stage. Random-effects meta-analyses were used to account for heterogeneity.

Results

15 eligible studies provided outcome data stratified by c-Met status in 2210 patients. Meta-analysis of the HRs indicated a significantly poorer Os in patients with high c-Met expression (average HR=2.112, 95%CI: 1.622-2.748). Subgroup analysis showed the prognostic effect of c-Met was identical in protein-level and gene-level based methodology. The same effect was also seen in Asian and Western ethnicity subgroup analysis. Meta-regression showed HR was not associated with disease stage.

Conclusions

Patients with tumors that harbor high c-Met expression are more likely to have a worse Os, with this prognostic effect independent of disease stage. c-Met status should be evaluated in clinical prognosis.

SUBMITTER: Yu S 

PROVIDER: S-EPMC3817069 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.

Yu Shan S   Yu Yiyi Y   Zhao Naiqing N   Cui Jianlan J   Li Wei W   Liu Tianshu T  

PloS one 20131104 11


<h4>Background</h4>c-Met has been recognized as an important therapeutic target in gastric cancer, but the prognostic property of the c-Met status is still unclear. We aimed to characterize the prognostic effect of c-Met by systematic review and meta-analysis.<h4>Methods</h4>We identified 15 studies assessing survival in gastric cancer by c-Met status. Effect measure of interest was hazard ratio (HR) for survival. Meta-regression was performed to estimate the relationship between HR and disease  ...[more]

Similar Datasets

| S-EPMC3885582 | biostudies-literature
| S-EPMC10015760 | biostudies-literature
| S-EPMC3931634 | biostudies-literature
| 2654299 | ecrin-mdr-crc
| S-EPMC3732238 | biostudies-literature
| S-EPMC6133557 | biostudies-literature
| S-EPMC6081180 | biostudies-literature
| S-EPMC8385102 | biostudies-literature
| S-EPMC4686173 | biostudies-literature
| S-EPMC6850601 | biostudies-literature